| HMC Capital Limited (HMC) ORDINARY FULLY PAID |
Financials |
$1,510 |
HMC Extends and Increases Corporate Facility
|
17 Nov 2025 9:15AM |
$2.900 |
$3.660 |
risen by
26.21%
|
|
HMC - Price-sensitive ASX Announcement
Full Release
Key Points
- HMC Capital extends revolving debt facility to $715 million.
- Facility maturity extended to 30 November 2027.
- Terms and pricing of the facility remain unchanged.
- Facility intended for underwriting and asset warehousing.
- HMC strategy focuses on maintaining zero core debt.
- Refinancing showcases lender confidence in HMC's business model.
- Extended facility supports HMC's strategic initiatives.
- Energy Transition capital partnering process is progressing well.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PMET Resources Inc (PMT) CHESS DEPOSITARY INTERESTS 10:1 |
Materials |
$269 |
PMET Resources Files NI 43-101 Technical Report
|
17 Nov 2025 9:15AM |
$0.395 |
$0.490 |
risen by
24.05%
|
|
| EV Resources Limited (EVR) ORDINARY FULLY PAID |
Materials |
$24 |
Director On Market Purchase
|
17 Nov 2025 9:14AM |
$0.010 |
$0.008 |
fallen by
20%
|
|
| IperionX Limited (IPX) ORDINARY FULLY PAID |
Materials |
$1,786 |
IperionX Response to Short Seller Report
|
17 Nov 2025 9:14AM |
$5.610 |
$5.320 |
fallen by
5.17%
|
|
IPX - Price-sensitive ASX Announcement
Full Release
Key Points
- IperionX Limited responded to a short seller report from Spruce Point Capital.
- Spruce Point Capital did not contact IperionX before releasing their report.
- IperionX focuses on expanding titanium production in Virginia.
- Supported by U.S. Government programs like ARPA-E, IBAS, and SBIR Phase III.
- Received U.S. DoW funding to enhance titanium production capabilities.
- Titan Critical Minerals Project aims to bolster U.S. titanium supply.
- IperionX is optimizing cost structures and expanding customer programs.
- Agreements in place with Ford and U.S. military for titanium products.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Diablo Resources Limited (DBO) ORDINARY FULLY PAID |
Materials |
$5 |
Notification regarding unquoted securities - DBO
|
17 Nov 2025 9:13AM |
$0.027 |
$0.022 |
fallen by
18.52%
|
|
| Sonic Healthcare Limited (SHL) ORDINARY FULLY PAID |
Health Care |
$11,358 |
Sonic Healthcare Sustainability Report 2025
|
17 Nov 2025 9:13AM |
$21.320 |
$22.980 |
risen by
7.79%
|
|
| Syrah Resources Limited (SYR) ORDINARY FULLY PAID |
Materials |
$367 |
US$8.5m DFC loan disbursement and interest deferral
|
17 Nov 2025 9:12AM |
$0.305 |
$0.280 |
fallen by
8.20%
|
|
SYR - Price-sensitive ASX Announcement
Full Release
Key Points
- Syrah to receive US$8.5 million disbursement from DFC.
- Interest payments deferred to May 2026.
- Warrants over Syrah shares issued to DFC, up to 1.3% holding.
- DFC's commitment to Balama Graphite Operation.
- Temporary waiver of unresolved loan default events.
- Strategic importance for US energy transition.
- Enhancing critical mineral supply chain security.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Catalina Resources Ltd (CTN) ORDINARY FULLY PAID |
Materials |
$9 |
Trading Halt
|
17 Nov 2025 9:12AM |
$0.004 |
$0.003 |
fallen by
14.29%
|
|
CTN - Price-sensitive ASX Announcement
Full Release
Key Points
- Catalina Resources Ltd (ASX: CTN) requested a trading halt.
- The trading halt is pending an announcement regarding a proposed capital raising.
- The halt will remain until either the announcement is made or normal trading resumes on 19 November 2025.
- Catalina Resources Ltd is not aware of any reason why the trading halt should not be granted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Algorae Pharmaceuticals Limited (1AI) ORDINARY FULLY PAID |
Health Care |
$25 |
Prospectus - Loyalty Options Offer
|
17 Nov 2025 9:12AM |
$0.009 |
$0.015 |
risen by
66.67%
|
|
1AI - Price-sensitive ASX Announcement
Full Release
Key Points
- Non-renounceable pro-rata entitlement offer for up to 337,678,946 Loyalty Options.
- Issue price of $0.001 per Loyalty Option with an exercise price of $0.014.
- Options expire on December 1, 2029.
- Offer aims to reward shareholders and potentially raise additional capital.
- Includes Shortfall Offer and Lead Manager Offer.
- Alignment Capital Pty Ltd appointed as lead manager.
- Professional advice recommended for participants.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Webjet Group Limited (WJL) ORDINARY FULLY PAID |
Consumer Discretionary |
$345 |
Webjet Group Limited 1H26 Results Briefing
|
17 Nov 2025 9:12AM |
$0.790 |
$0.880 |
risen by
11.39%
|
|
| Racura Oncology Ltd (RAC) ORDINARY FULLY PAID |
Health Care |
$462 |
Race Clinical Program Update
|
17 Nov 2025 9:11AM |
$3.280 |
$2.560 |
fallen by
21.95%
|
|
RAC - Price-sensitive ASX Announcement
Full Release
Key Points
- Race Oncology announced two new clinical trials for RC220 targeting Acute Myeloid Leukemia (AML) and Non-Small Cell Lung Cancer (NSCLC).
- The Phase 3 AML trial aims to bridge RC110 to RC220, providing a rapid, low-cost pathway to regulatory approval.
- The NSCLC trial is in advanced planning, leveraging the G4-binding mechanism of (E,E)-bisantrene to potentially delay resistance to EGFR tyrosine kinase inhibitors.
- RC220 has been shown to delay or prevent TKI resistance in lung cancer preclinical studies.
- The company is financially positioned with $11.3 million in cash and equivalents as of September 2025.
- Race Oncology is using a combination of proprietary drugs and existing AML treatments in their trials.
- Significant market potential exists in the EGFRm TKI space, with more than US$10 billion in annual sales.
- Race Oncology is prioritizing cardioprotective and anticancer activity of RC220 in combination with doxorubicin.
- Upcoming webinar scheduled to discuss the clinical programs and future directions.
- Race Oncology remains well funded to support all announced trials and programs until mid-2027.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kingsgate Consolidated Limited (KCN) ORDINARY FULLY PAID |
Materials |
$1,287 |
TAFTA Update
|
17 Nov 2025 9:11AM |
$4.640 |
$4.860 |
risen by
4.74%
|
|
KCN - Price-sensitive ASX Announcement
Full Release
Key Points
- Kingsgate Consolidated Limited is negotiating a resolution of the TAFTA dispute with Thailand.
- The company has previously released details regarding the TAFTA Update on 1 October 2025.
- The announcement regarding the negotiations has been authorized by the Board of Kingsgate Consolidated Limited.
- Ross Smyth-Kirk OAM is the Executive Chairman of Kingsgate Consolidated Limited.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orcoda Limited (ODA) ORDINARY FULLY PAID |
Information Technology |
$12 |
Managing Director Succession Update
|
17 Nov 2025 9:11AM |
$0.069 |
$0.065 |
fallen by
5.80%
|
|
ODA - Price-sensitive ASX Announcement
Full Release
Key Points
- Orcoda Limited announced the appointment of Mr. Patrick Bodegraven as Managing Director effective 17 November 2025.
- Mr. Geoff Jamieson, after 13 years as Managing Director/CFO at Orcoda, will step down but remain as CFO and Executive Director part-time.
- Patrick Bodegraven has extensive leadership experience with global technology leaders and a proven record of business development.
- The transition is part of a planned succession to lead Orcoda into its next growth phase.
- The agreement for the Managing Director includes a 12-month term with annual renewal and a $350,000 annual remuneration.
- Orcoda aims to enhance operational efficiencies and connectivity through integrated smart technology solutions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Whitehaven Coal Limited (WHC) ORDINARY FULLY PAID |
Energy |
$6,433 |
Update - Notification of buy-back - WHC
|
17 Nov 2025 9:10AM |
$7.020 |
$7.770 |
risen by
10.68%
|
|
| Capricorn Metals Ltd (CMM) ORDINARY FULLY PAID |
Materials |
$6,302 |
Security Class Suspension from Quotation
|
17 Nov 2025 9:09AM |
$14.130 |
$13.820 |
fallen by
2.19%
|
|
CMM - Price-sensitive ASX Announcement
Full Release
Key Points
- The securities of Capricorn Metals Ltd have been suspended from quotation.
- The suspension is in accordance with Listing Rule 17.3.4.
- The suspension is pending compliance with Listing Rule 2.5.
- The security class code affected is CMMO.
- The suspension does not apply to other quoted securities of Capricorn Metals Ltd.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Regal Investment Fund (RF1) ORDINARY UNITS FULLY PAID |
Financials |
$715 |
Weekly Estimate NTA for 14.11.2025
|
17 Nov 2025 9:09AM |
$3.280 |
$3.390 |
risen by
3.35%
|
|
| Biotron Limited (BIT) ORDINARY FULLY PAID |
Health Care |
$5 |
Chair's Address to Shareholders
|
17 Nov 2025 9:09AM |
$0.004 |
$0.003 |
fallen by
37.50%
|
|
| West Wits Mining Limited (WWI) ORDINARY FULLY PAID |
Materials |
$222 |
Proposed issue of securities - WWI
|
17 Nov 2025 9:07AM |
$0.051 |
$0.058 |
risen by
13.73%
|
|
| EVZ Limited (EVZ) ORDINARY FULLY PAID |
Industrials |
$27 |
Ceasing to be a substantial holder
|
17 Nov 2025 9:07AM |
$0.225 |
$0.225 |
fallen by
0%
|
|
| TPG Telecom Limited (TPG) ORDINARY FULLY PAID |
Communication Services |
$7,597 |
Proposed issue of securities - TPG
|
17 Nov 2025 9:06AM |
$3.800 |
$3.870 |
risen by
1.84%
|
|
| Regal Investment Fund (RF1) ORDINARY UNITS FULLY PAID |
Financials |
$715 |
Update - Notification of buy-back - RF1
|
17 Nov 2025 9:05AM |
$3.280 |
$3.390 |
risen by
3.35%
|
|
| West Wits Mining Limited (WWI) ORDINARY FULLY PAID |
Materials |
$222 |
Issue of Facility Drawdown Notice to Nebari
|
17 Nov 2025 9:04AM |
$0.051 |
$0.058 |
risen by
13.73%
|
|
WWI - Price-sensitive ASX Announcement
Full Release
Key Points
- West Wits Mining Limited issued a drawdown notice to Nebari Natural Resources Credit Fund II LP.
- The drawdown is for Tranche 1 amounting to US$12.5 million.
- The funds will be used for the development of the Qala Shallows Gold Project.
- The first gold pour is targeted for March 2026.
- The Facility allows for up to three tranches totaling US$35 million, subject to future conditions.
- The announcement about the Facility was initially made on 29 September 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Megaport Limited (MP1) ORDINARY FULLY PAID |
Information Technology |
$2,228 |
Cleansing Notice
|
17 Nov 2025 9:03AM |
$13.720 |
$12.650 |
fallen by
7.80%
|
|
| Sunshine Metals Limited (SHN) ORDINARY FULLY PAID |
Materials |
$49 |
Final diamond drill results include 4.5m @ 17.23g/t Au
|
17 Nov 2025 9:03AM |
$0.021 |
$0.019 |
fallen by
9.52%
|
|
SHN - Price-sensitive ASX Announcement
Full Release
Key Points
- Final diamond drill results include 4.5m @ 17.23g/t Au.
- Exploration focused on vein structures with quartz-adularia veining.
- Significant gold intercepts reported in multiple drill holes.
- Future exploration plans to expand on identified mineralized zones.
- Potential for resource expansion based on current drilling results.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Metal Bank Limited (MBK) ORDINARY FULLY PAID |
Materials |
$18 |
High Grade Gold Mineralisation from Seven Leaders Drilling
|
17 Nov 2025 9:03AM |
$0.015 |
$0.021 |
risen by
40%
|
|
MBK - Price-sensitive ASX Announcement
Full Release
Key Points
- Hastings Technology Metals Ltd conducted RC drilling at the Seven Leaders prospect within the Whiteheads Gold Project, confirming high-grade gold results.
- Metal Bank Limited (MBK) is set to acquire the Seven Leaders prospect from Hastings, subject to shareholder approval.
- The drilling program returned notable intersections, including 5m @ 15.17g/t Au and 35m @ 1.94g/t Au from surface.
- Drilling has confirmed mineralisation over a 250m strike, supporting a Maiden Resource Estimate due in December 2025.
- MBK aims to transform into a mid-tier mining company, progressing the Seven Leaders prospect into production by 2026.
- The acquisition of the Whiteheads Gold Project is part of MBK's growth strategy, including the Livingstone Gold Project and Queensland Critical Minerals Project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
